These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 39137963)
1. Genetics of prostate cancer: a review of latest evidence. Hall R; Bancroft E; Pashayan N; Kote-Jarai Z; Eeles RA J Med Genet; 2024 Sep; 61(10):915-926. PubMed ID: 39137963 [TBL] [Abstract][Full Text] [Related]
2. Prostate cancer screening in BRCA and Lynch syndrome mutation carriers. Castro E; Goh CL; Eeles RA Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714454 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes. Kote-Jarai Z; Mikropoulos C; Leongamornlert DA; Dadaev T; Tymrakiewicz M; Saunders EJ; Jones M; Jugurnauth-Little S; Govindasami K; Guy M; Hamdy FC; Donovan JL; Neal DE; Lane JA; Dearnaley D; Wilkinson RA; Sawyer EJ; Morgan A; Antoniou AC; Eeles RA; Ann Oncol; 2015 Apr; 26(4):756-761. PubMed ID: 25595936 [TBL] [Abstract][Full Text] [Related]
4. Updates in Prostate Cancer Research and Screening in Men at Genetically Higher Risk. Bancroft EK; Raghallaigh HN; Page EC; Eeles RA Curr Genet Med Rep; 2021; 9(4):47-58. PubMed ID: 34790437 [TBL] [Abstract][Full Text] [Related]
5. Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology. Drake BF; Keane TE; Mosley CM; Adams SA; Elder KT; Modayil MV; Ureda JR; Hebert JR J S C Med Assoc; 2006 Aug; 102(7):241-9. PubMed ID: 17319238 [TBL] [Abstract][Full Text] [Related]
6. Genetic predisposition to prostate cancer. Benafif S; Eeles R Br Med Bull; 2016 Dec; 120(1):75-89. PubMed ID: 27941040 [TBL] [Abstract][Full Text] [Related]
7. Family History of Prostate Cancer and Survival Outcomes in the UK Genetic Prostate Cancer Study. Brook MN; Ní Raghallaigh H; Govindasami K; Dadaev T; Rageevakumar R; Keating D; Hussain N; Osborne A; Lophatananon A; ; Muir KR; Kote-Jarai Z; Eeles RA Eur Urol; 2023 Mar; 83(3):257-266. PubMed ID: 36528478 [TBL] [Abstract][Full Text] [Related]
8. Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications. Brandão A; Paulo P; Teixeira MR Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708810 [TBL] [Abstract][Full Text] [Related]
9. Prostate cancer risk in men of differing genetic ancestry and approaches to disease screening and management in these groups. McHugh J; Saunders EJ; Dadaev T; McGrowder E; Bancroft E; Kote-Jarai Z; Eeles R Br J Cancer; 2022 Jun; 126(10):1366-1373. PubMed ID: 34923574 [TBL] [Abstract][Full Text] [Related]
10. The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer. Castro E; Mikropoulos C; Bancroft EK; Dadaev T; Goh C; Taylor N; Saunders E; Borley N; Keating D; Page EC; Saya S; Hazell S; Livni N; deSouza N; Neal D; Hamdy FC; Kumar P; Antoniou AC; Kote-Jarai Z; ; Eeles RA Oncologist; 2016 Jun; 21(6):716-22. PubMed ID: 27151655 [TBL] [Abstract][Full Text] [Related]
11. Self-Identified African Americans and prostate cancer risk: West African genetic ancestry is associated with prostate cancer diagnosis and with higher Gleason sum on biopsy. Grizzle WE; Kittles RA; Rais-Bahrami S; Shah E; Adams GW; DeGuenther MS; Kolettis PN; Nix JW; Bryant JE; Chinsky R; Kearns JE; Dehimer K; Terrin N; Chang H; Gaston SM Cancer Med; 2019 Nov; 8(16):6915-6922. PubMed ID: 31568648 [TBL] [Abstract][Full Text] [Related]
12. The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers. Bancroft EK; Page EC; Brook MN; Pope J; Thomas S; Myhill K; Helfand BT; Talaty P; Ong KR; Douglas E; Cook J; Rosario DJ; Salinas M; Buys SS; Anson J; Davidson R; Longmuir M; Side L; Eccles DM; Tischkowitz M; Taylor A; Cruellas M; Ballestero EP; Cleaver R; Varughese M; Barwell J; LeButt M; Greenhalgh L; Hart R; Azzabi A; Jobson I; Cogley L; Evans DG; Rothwell J; Taylor N; Hogben M; Saya S; ; Eeles RA; Aaronson NK BJU Int; 2024 Sep; 134(3):484-500. PubMed ID: 38839570 [TBL] [Abstract][Full Text] [Related]
13. Genetic predisposition to prostate cancer: an update. Ni Raghallaigh H; Eeles R Fam Cancer; 2022 Jan; 21(1):101-114. PubMed ID: 33486571 [TBL] [Abstract][Full Text] [Related]
14. Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers. Page EC; Bancroft EK; Brook MN; Assel M; Hassan Al Battat M; Thomas S; Taylor N; Chamberlain A; Pope J; Raghallaigh HN; Evans DG; Rothwell J; Maehle L; Grindedal EM; James P; Mascarenhas L; McKinley J; Side L; Thomas T; van Asperen C; Vasen H; Kiemeney LA; Ringelberg J; Jensen TD; Osther PJS; Helfand BT; Genova E; Oldenburg RA; Cybulski C; Wokolorczyk D; Ong KR; Huber C; Lam J; Taylor L; Salinas M; Feliubadaló L; Oosterwijk JC; van Zelst-Stams W; Cook J; Rosario DJ; Domchek S; Powers J; Buys S; O'Toole K; Ausems MGEM; Schmutzler RK; Rhiem K; Izatt L; Tripathi V; Teixeira MR; Cardoso M; Foulkes WD; Aprikian A; van Randeraad H; Davidson R; Longmuir M; Ruijs MWG; Helderman van den Enden ATJM; Adank M; Williams R; Andrews L; Murphy DG; Halliday D; Walker L; Liljegren A; Carlsson S; Azzabi A; Jobson I; Morton C; Shackleton K; Snape K; Hanson H; Harris M; Tischkowitz M; Taylor A; Kirk J; Susman R; Chen-Shtoyerman R; Spigelman A; Pachter N; Ahmed M; Ramon Y Cajal T; Zgajnar J; Brewer C; Gadea N; Brady AF; van Os T; Gallagher D; Johannsson O; Donaldson A; Barwell J; Nicolai N; Friedman E; Obeid E; Greenhalgh L; Murthy V; Copakova L; Saya S; McGrath J; Cooke P; Rønlund K; Richardson K; Henderson A; Teo SH; Arun B; Kast K; Dias A; Aaronson NK; Ardern-Jones A; Bangma CH; Castro E; Dearnaley D; Eccles DM; Tricker K; Eyfjord J; Falconer A; Foster C; Gronberg H; Hamdy FC; Stefansdottir V; Khoo V; Lindeman GJ; Lubinski J; Axcrona K; Mikropoulos C; Mitra A; Moynihan C; Rennert G; Suri M; Wilson P; Dudderidge T; ; Offman J; Kote-Jarai Z; Vickers A; Lilja H; Eeles RA Eur Urol; 2019 Dec; 76(6):831-842. PubMed ID: 31537406 [TBL] [Abstract][Full Text] [Related]
15. Perceived family history risk and symptomatic diagnosis of prostate cancer: the North Carolina Prostate Cancer Outcomes study. Spain P; Carpenter WR; Talcott JA; Clark JA; Do YK; Hamilton RJ; Galanko JA; Jackman A; Godley PA Cancer; 2008 Oct; 113(8):2180-7. PubMed ID: 18798229 [TBL] [Abstract][Full Text] [Related]
16. The psychological impact of undergoing genetic-risk profiling in men with a family history of prostate cancer. Bancroft EK; Castro E; Bancroft GA; Ardern-Jones A; Moynihan C; Page E; Taylor N; Eeles RA; Rowley E; Cox K Psychooncology; 2015 Nov; 24(11):1492-9. PubMed ID: 25872100 [TBL] [Abstract][Full Text] [Related]
17. Identification of Germline Genetic Variants that Increase Prostate Cancer Risk and Influence Development of Aggressive Disease. Saunders EJ; Kote-Jarai Z; Eeles RA Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33673083 [TBL] [Abstract][Full Text] [Related]
18. PRState: Incorporating genetic ancestry in prostate cancer risk scores for men of African ancestry. Pagadala MS; Linscott JA; Talwar JV; Seibert TM; Rose B; Lynch J; Panizzon M; Hauger R; Hansen MH; Sammon JD; Hayn MH; Kader K; Carter H; Ryan ST BMC Cancer; 2022 Dec; 22(1):1289. PubMed ID: 36494783 [TBL] [Abstract][Full Text] [Related]
19. The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer. Maia S; Cardoso M; Paulo P; Pinheiro M; Pinto P; Santos C; Pinto C; Peixoto A; Henrique R; Teixeira MR Fam Cancer; 2016 Jan; 15(1):111-21. PubMed ID: 26289772 [TBL] [Abstract][Full Text] [Related]
20. Association of Inherited Mutations in DNA Repair Genes with Localized Prostate Cancer. Lee DJ; Hausler R; Le AN; Kelly G; Powers J; Ding J; Feld E; Desai H; Morrison C; Doucette A; Gabriel P; Genetics Center R; Judy RL; Weaver J; Kember R; Damrauer SM; Rader DJ; Domchek SM; Narayan V; Schwartz LE; Maxwell KN Eur Urol; 2022 Jun; 81(6):559-567. PubMed ID: 34711450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]